Showing results (171-180 of 348) with videos related to
Sort By:
Pageof 35
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 8, 2012
[A case of anstomotic stricture after esophagectomy sufficiently treated by endoscopic triamcinolone injection therapy]Jin Matsuyama, Yukio Fukushima, Masayuki Hiraki, et al.Surgical Case Reports|October 2, 2020
Simultaneous triple cancer of the esophagus, pancreas and rectum treated with multimodal strategies: a case reportHiroki Imamura, Hajime Hirose, Shunji Endo, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2021
[A Case of Neuroendocrine Carcinoma of Ascending Colon with Early Recurrence after Surgery]Hiroki Imamura, Hajime Hirose, Shinichi Yoshioka, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 14, 2025
[A Case of Appendiceal Goblet Cell Carcinoma]Yoshitaka Okauchi, Shinichi Yoshioka, Ryo Ikeshima, et al.Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|June 18, 2024
Directly measured strain patterns of the anterior talofibular and calcaneofibular ligaments after isolated ATFL repair in a combined ATFL and CFL injury: A cadaver studyMasato Takao, Satoru Ozeki, Maya Kubo, et al.Healthcare (Basel, Switzerland)|September 23, 2022
An Automated Algorithm for Determining Sleep Using Single-Channel Electroencephalography to Detect Delirium: A Prospective Observational Study in Intensive Care UnitsKentaro Matsui, Nobuo Sato, Masafumi Idei, et al.Scientific Reports|August 13, 2016
Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced NeurotoxicityYanchun Pan, Takuji Daito, Yo Sasaki, et al.Proceedings of the National Academy of Sciences of the United States of America|November 29, 2012
SCG10 is a JNK target in the axonal degeneration pathwayJung Eun Shin, Bradley R Miller, Elisabetta Babetto, et al.Plos One|April 17, 2026
Dysregulated lactate metabolism synergizes with ALS genetic risk factors to accelerate motor declineShweta Tendulkar, Tong Wu, Amy Strickland, et al.Experimental Neurology|February 23, 2020
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axonsYo Sasaki, Thomas M Engber, Robert O Hughes, et al.Pageof 35